Publications by authors named "Harduin Reeg"

Claim this Profile
L
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?
Franz Heigl, Tobias Pflederer, Reinhard Klingel, Reinhard Hettich, Norbert Lotz, Harduin Reeg

Atheroscler Suppl· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidological competence centres and networks: Future perspectives to improve healthcare of patients with disorders of lipid metabolism.
Franz Heigl, Tobias Pflederer, Volker Schettler, Peter Grützmacher, Ulrich Julius, Harduin Reeg

Atheroscler Suppl· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
Franz Heigl, Reinhard Hettich, Norbert Lotz, Harduin Reeg, Tobias Pflederer

Atheroscler Suppl· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease.
Franz Heigl, Reinhard Hettich, Norbert Lotz, Harduin Reeg, Tobias Pflederer

Clin Res Cardiol Suppl· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indication and implementation of lipidapheresis, rheopheresis, or immunoadsorption (lessons learnt from Germany's largest apheresis center).
Franz Heigl, Reinhard Hettich, Norbert Lotz, Harduin Reeg, Bernadette Eder

Atheroscler Suppl· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis